By Mill Chart
Last update: Oct 4, 2022
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) was identified as a Technical Breakout Setup Pattern by our stockscreener. Such a pattern occurs when we see a pause in a strong uptrend: after a strong rise the stock is consolidating a bit and at some point the trend may be continued. Whether this actually happens can not be predicted of course, but it may be a good idea to keep and eye on NASDAQ:VRTX.
ChartMill assigns a Technical Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple technical indicators and properties.
Taking everything into account, VRTX scores 9 out of 10 in our technical rating. This is due to a consistent performance in both the short and longer term time frames. Also compared to the overall market, VRTX is showing a nice and steady performance.
Next to the Technical Rating, the Setup Rating of a stock determines to which extend the stock is consolidating. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. For NASDAQ:VRTX this score is currently 8:
Besides having an excellent technical rating, VRTX also presents a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is very little resistance above the current price. There is a support zone below the current price at 287.58, a Stop Loss order could be placed below this zone. Very recently a Pocket Pivot signal was observed. This is another positive sign.
One way to play this would be to wait for the actual breakout to happen and buy when the stock breaks out above the current consolidation zone. A possible place for a stop loss would be below this zone.
Of course, there are many ways to trade or not trade NASDAQ:VRTX and this article should in no way be interpreted as trading advice. The article is purely based on an automated technical analysis and just points out the technical observations. Always make your own analysis and trade at your own responsibility.
Every day, new breakout setups can be found on ChartMill in our Breakout analyzer.
VERTEX PHARMACEUTICALS INC
NASDAQ:VRTX (3/28/2024, 8:00:02 PM)
After market: 418.01 0 (0%)418.01
+0.69 (+0.17%)
The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia.
These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips As we step into March 2024, the spotlight is turning towards the biotech sector...
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.
These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.
These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.
It's always a good time to buy great stocks with excellent prospects.
There's no need for delays in buying these great stocks.
Vertex Pharmaceuticals already has a fantastic business, and it could get much bigger in the future.